Wednesday, January 15
Oncology remains one of the key challenges for payors. It is an expensive condition to treat and manage, with treatment costs expected to reach $207 billion by the end of next year.1 In response, CVS Health is announcing a new initiative to target the complex cost and patient management needs related to cancer: Transform Oncology Care. Featuring a first-of-its-kind precision medicine strategy, this program uses genomic testing results at the point of prescribing to help patients start on the best treatment, faster, while creating an opportunity to match eligible patients to clinical trials. Transform Oncology Care also leverages our local footprint and integrated assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.
During this session, we will explore